Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 167045, 10 pages
http://dx.doi.org/10.1155/2010/167045
Research Article

Identification of a New Peptide for Fibrosarcoma Tumor Targeting and Imaging In Vivo

1Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei 11031, Taiwan
2Department of Otolaryngology, Wan-Fang Hospital, Taipei Medical University, Taipei 116, Taiwan
3Institute of Biomedical Materials and Engineering, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan
4Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei 112, Taiwan
5Genomics research Center, Academia Sinica, Taipei 115, Taiwan
6Section of Hematology-Oncology, Department of Medicine, Taipei Medical University, Taipei 11217, Taiwan
7Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan
8Institute of Radiological Science, National Yang-Ming University, Taipei 112, Taiwan
9Institute of Nuclear Energy Research, Taoyuan 32546, Taiwan
10Department of Surgery, School of Medicine, Taipei Medical University-Shuang Ho Hospital, Taipei 110, Taiwan
11Department of Microbiology and Immunology, School of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan

Received 14 April 2010; Revised 9 August 2010; Accepted 2 October 2010

Academic Editor: Elvira Gonzalez De Mejia

Copyright © 2010 Chia-Che Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Genoni, A. M. Biraima, B. Bode, A. C. Shah, M. B. Winkler, and M. I. Turina, “Combined resection and adjuvant therapy improves prognosis of sarcomas of the pulmonary trunk,” Journal of Cardiovascular Surgery, vol. 42, no. 6, pp. 829–833, 2001. View at Google Scholar · View at Scopus
  2. H. Tsuchiya, K. Tomita, Y. Mori, N. Asada, and N. Yamamoto, “Marginal excision for osteosarcoma with caffeine assisted chemotherapy,” Clinical Orthopaedics and Related Research, no. 358, pp. 27–35, 1999. View at Google Scholar · View at Scopus
  3. M. D. Cameron, E. E. Schmidt, N. Kerkvliet et al., “Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency,” Cancer Research, vol. 60, no. 9, pp. 2541–2546, 2000. View at Google Scholar · View at Scopus
  4. J.-T. Zhang and Y. Liu, “Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment,” Cancer Treatment Reviews, vol. 33, no. 8, pp. 741–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Pérez-Tomás, “Multidrug resistance: retrospect and prospects in anti-cancer drug treatment,” Current Medicinal Chemistry, vol. 13, no. 16, pp. 1859–1876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Nogawa, T. Yuasa, S. Kimura et al., “Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models,” Cancer Letters, vol. 217, no. 2, pp. 243–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Yamamoto, M. Yang, P. Jiang et al., “Real-time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases,” Clinical and Experimental Metastasis, vol. 20, no. 2, pp. 181–185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. D. K. Marsee, D. H. Y. Shen, L. R. MacDonald et al., “Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography,” Cancer Gene Therapy, vol. 11, no. 2, pp. 121–127, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. W.-P. Deng, C.-C. Wu, C.-C. Lee et al., “Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 877–884, 2006. View at Google Scholar · View at Scopus
  10. J. C. Reubi and H. R. Maecke, “Peptide-based probes for cancer imaging,” Journal of Nuclear Medicine, vol. 49, no. 11, pp. 1735–1738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Zitzmann, W. Mier, A. Schad et al., “A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy,” Clinical Cancer Research, vol. 11, no. 1, pp. 139–146, 2005. View at Google Scholar · View at Scopus
  12. V. Rufini, M. L. Calcagni, and R. P. Baum, “Imaging of Neuroendocrine Tumors,” Seminars in Nuclear Medicine, vol. 36, no. 3, pp. 228–247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. P. J. Schroeder, W. M. V. Weerden, C. Bangma, E. P. Krenning, and M. D. Jong, “Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues,” Methods, vol. 48, no. 2, pp. 200–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Van De Wiele, P. Phonteyne, P. Pauwels et al., “Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry,” Journal of Nuclear Medicine, vol. 49, no. 2, pp. 260–264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Leiss, K. Beckmann, A. Girós, M. Costell, and R. Fässler, “The role of integrin binding sites in fibronectin matrix assembly in vivo,” Current Opinion in Cell Biology, vol. 20, no. 5, pp. 502–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Haubner and C. Decristoforo, “Radiolabelled RGD peptides and peptidomimetics for tumour targeting,” Frontiers in Bioscience, vol. 14, pp. 872–886, 2009. View at Google Scholar · View at Scopus
  17. R. Brissette and N. I. Goldstein, “The use of phage display peptide libraries for basic and translational research,” Methods in Molecular Biology, vol. 383, pp. 203–213, 2007. View at Google Scholar · View at Scopus
  18. K. C. Brown, “Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications,” Current Pharmaceutical Design, vol. 16, no. 9, pp. 1040–1054, 2010. View at Publisher · View at Google Scholar
  19. W. K. Yang, L. Y. Ch'ang, C. K. Koh, F. E. Myer, and M. D. Yang, “Mouse endogenous retroviral long-terminal-repeat (LTR) elements and environmental carcinogenesis,” Progress in nucleic acid research and molecular biology, vol. 36, pp. 247–266, 1989. View at Google Scholar · View at Scopus
  20. R. Haubner, “αvβ3-integrin imaging: a new approach to characterise angiogenesis?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 13, pp. S54–S63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. E. J. Rolleman, M. Melis, R. Valkema, O. C. Boerman, E. P. Krenning, and M. de Jong, “Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues,” European Journal of Nuclear Medicine and Molecular Imaging, pp. 1–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. M. Behr, D. M. Goldenberg, and W. Becker, “Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations,” European Journal of Nuclear Medicine, vol. 25, no. 2, pp. 201–212, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Komoriya, L. J. Green, M. Mervic, S. S. Yamada, K. M. Yamada, and M. J. Humphries, “The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine,” Journal of Biological Chemistry, vol. 266, no. 23, pp. 15075–15079, 1991. View at Google Scholar · View at Scopus
  24. E. J. Rodenberg and F. M. Pavalko, “Peptides derived from fibronectin type III connecting segments promote endothelial cell adhesion but not platelet adhesion: implications in tissue-engineered vascular grafts,” Tissue Engineering, vol. 13, no. 11, pp. 2653–2666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Okochi, S. Nomura, C. Kaga, and H. Honda, “Peptide array-based screening of human mesenchymal stem cell-adhesive peptides derived from fibronectin type III domain,” Biochemical and Biophysical Research Communications, vol. 371, no. 1, pp. 85–89, 2008. View at Publisher · View at Google Scholar · View at Scopus